Fortis Healthcare Limited
NSE: FORTIS BSE: FORTIS
Prev Close
823.7
Open Price
830.8
Volume
3,454,577
Today Low / High
828.65 / 849.7
52 WK Low / High
480.55 / 849.7
Range
804 - 889
Prev Close
824.55
Open Price
827.2
Volume
120,246
Today Low / High
827.2 / 849.4
52 WK Low / High
480.45 / 849.4
Range
804 - 889
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 846.55 (target range: 804 - 889), reflecting a change of 22.85 (2.77407%). On the BSE, it is listed at 846.75 (target range: 804 - 889), showing a change of 22.2 (2.69238%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Fortis Healthcare Limited Graph
Fortis Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Fortis Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 846.55, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 846.75 | 855.22 | 769.70 - 940.74 |
| 863.69 | 690.95 - 1,036.42 | ||
| 872.15 | 610.51 - 1,133.80 | ||
| Bearish Scenario | 846.75 | 838.28 | 754.45 - 922.11 |
| 829.82 | 663.85 - 995.78 | ||
| 821.35 | 574.94 - 1,067.75 |
Overview of Fortis Healthcare Limited
ISIN
INE061F01013
Industry
Medical - Care Facilities
Vol.Avg
1,819,770
Market Cap
639,109,694,900
Last Dividend
1
Official Website
IPO Date
2007-05-09
DCF Diff
371.24
DCF
465
Financial Ratios Every Investor Needs
Stock Dividend of FORTIS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-25 | July 25, 25 | 1 | 1 | 2025-07-25 | 2025-09-10 | |
| 2024-07-24 | July 24, 24 | 1 | 1 | 2024-07-24 | 2024-08-31 | |
| 2023-07-20 | July 20, 23 | 1 | 1 | 2023-07-20 | 2023-08-31 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 7,782.75 Cr | 4,628.05 Cr | 3,154.70 Cr | 0.4053 | 0.00 Cr | 0.00 Cr | 1,084.86 Cr | 774.21 Cr | 10.26 | 1,587.94 Cr | 0.0995 |
| 2024-03-31 | 6,835.09 Cr | 4,540.22 Cr | 2,294.87 Cr | 0.3357 | 0.00 Cr | 127.15 Cr | 912.28 Cr | 598.88 Cr | 7.93 | 1,307.45 Cr | 0.0876 |
| 2023-03-31 | 6,297.63 Cr | 2,766.17 Cr | 3,531.46 Cr | 0.5608 | 0.00 Cr | 124.44 Cr | 784.39 Cr | 588.73 Cr | 7.80 | 1,228.79 Cr | 0.0935 |
| 2022-03-31 | 5,638.65 Cr | 1,417.98 Cr | 4,220.67 Cr | 0.7485 | 0.01 Cr | 1,234.51 Cr | 760.27 Cr | 555.12 Cr | 7.35 | 1,403.43 Cr | 0.0984 |
| 2021-03-31 | 3,961.33 Cr | 1,844.01 Cr | 2,117.32 Cr | 0.5345 | 0.05 Cr | 118.89 Cr | 118.27 Cr | -109.76 Cr | -1.45 | 444.48 Cr | -0.0277 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 507.99 Cr | 13,691.53 Cr | 4,522.14 Cr | 8,916.5200 Cr | 2,475.10 Cr | 1,967.11 Cr | 115.30 Cr | 6,252.06 Cr | 0.00 Cr | 0.00 Cr | 169.10 Cr | 1,607.3200 Cr |
| 2024-03-31 | 235.27 Cr | 13,288.78 Cr | 4,732.64 Cr | 7,662.8969 Cr | 1,155.02 Cr | 919.75 Cr | 107.42 Cr | 5,829.02 Cr | 85.62 Cr | 0.00 Cr | -80.38 Cr | 3,170.1687 Cr |
| 2023-03-31 | 141.08 Cr | 12,433.60 Cr | 4,333.21 Cr | 7,242.2600 Cr | 925.72 Cr | 784.64 Cr | 122.84 Cr | 5,077.31 Cr | 380.36 Cr | 2,313.97 Cr | 210.30 Cr | 1,425.8800 Cr |
| 2022-03-31 | 143.23 Cr | 11,884.75 Cr | 4,876.49 Cr | 6,178.2421 Cr | 1,254.93 Cr | 1,111.70 Cr | 122.90 Cr | 5,143.69 Cr | 369.64 Cr | 2,972.21 Cr | 103.60 Cr | 1,269.4336 Cr |
| 2021-03-31 | 261.23 Cr | 11,154.69 Cr | 4,436.88 Cr | 6,119.8112 Cr | 1,530.55 Cr | 1,269.32 Cr | 76.76 Cr | 5,178.51 Cr | 351.12 Cr | 0.07 Cr | 186.03 Cr | 1,233.0390 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,423.9300 Cr | -779.3800 Cr | -713.8400 Cr | 577.0000 Cr | -69.7546 Cr | 99.9100 Cr | -846.9300 Cr | 774.2100 Cr | 1,310.4500 Cr | -108.8700 Cr | -8.6400 Cr |
| 2024-03-31 | 1,100.0967 Cr | -920.9991 Cr | -86.4583 Cr | 157.6303 Cr | 124.5193 Cr | 169.6646 Cr | -942.4664 Cr | 598.8800 Cr | 185.4810 Cr | -86.0318 Cr | 13.8900 Cr |
| 2023-03-31 | 822.2400 Cr | -373.7000 Cr | -471.2200 Cr | 375.0000 Cr | -21.4600 Cr | 45.1400 Cr | -447.2400 Cr | 813.6800 Cr | -281.8270 Cr | -15.9774 Cr | -2.0000 Cr |
| 2022-03-31 | 865.3919 Cr | -514.3751 Cr | -517.3114 Cr | 649.9026 Cr | -152.5248 Cr | 66.6004 Cr | -215.4893 Cr | 987.7869 Cr | -339.6121 Cr | 0.0000 Cr | -38.2210 Cr |
| 2021-03-31 | 485.4920 Cr | -135.0977 Cr | -142.9286 Cr | 266.9860 Cr | 212.0122 Cr | 219.1252 Cr | -218.5060 Cr | 43.2954 Cr | 49.4160 Cr | 0.0000 Cr | 1.4159 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2,007.20 Cr | 1,164.85 Cr | 842.35 Cr | 0.4197 | 285.48 Cr | 183.89 Cr | 2.44 | 429.64 Cr | 0.0916 |
| 2024-12-31 | 1,928.26 Cr | 867.24 Cr | 1,061.02 Cr | 0.5502 | 277.79 Cr | 247.90 Cr | 3.28 | 421.87 Cr | 0.1286 |
| 2024-09-30 | 1,988.39 Cr | 869.67 Cr | 1,118.72 Cr | 0.5626 | 339.78 Cr | 176.46 Cr | 2.34 | 392.53 Cr | 0.0887 |
| 2024-06-30 | 1,858.90 Cr | 1,232.73 Cr | 626.17 Cr | 0.3368 | 251.72 Cr | 165.96 Cr | 2.20 | 355.73 Cr | 0.0893 |
| 2024-03-31 | 1,785.88 Cr | 1,147.21 Cr | 638.67 Cr | 0.3576 | 289.11 Cr | 178.73 Cr | 2.37 | 393.98 Cr | 0.1001 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 507.99 Cr | 0.00 Cr | 507.99 Cr | 784.49 Cr | 115.30 Cr | 1,471.36 Cr | 6,252.06 Cr | 13,691.53 Cr | 4,522.14 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 600.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -8,729.65 Cr |
| 2024-09-30 | 266.21 Cr | 366.06 Cr | 632.27 Cr | 0.00 Cr | 114.80 Cr | 1,592.71 Cr | 6,013.25 Cr | 13,596.82 Cr | 4,867.17 Cr |
| 2024-06-30 | -600.30 Cr | 1,200.59 Cr | 600.30 Cr | 0.00 Cr | 0.00 Cr | 600.30 Cr | 0.00 Cr | 0.00 Cr | -8,556.14 Cr |
| 2024-03-31 | 598.40 Cr | 400.76 Cr | 598.40 Cr | 627.83 Cr | 107.42 Cr | 1,420.59 Cr | 5,808.02 Cr | 13,288.78 Cr | 4,732.64 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 183.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 247.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 176.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 165.96 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 178.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,267.40 | ₹1,232,099,107,800.00 | ₹2,393,702.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,363.50 | ₹1,058,760,847,500.00 | ₹454,912.00 |
| Fortis Healthcare Limited | FORTIS | ₹846.55 | ₹639,109,694,900.00 | ₹3,454,577.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,980.60 | ₹404,757,396,600.00 | ₹295,832.00 |
| Global Health Limited | MEDANTA | ₹1,326.20 | ₹356,297,382,694.00 | ₹182,872.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹789.35 | ₹315,849,719,650.00 | ₹1,291,315.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹595.05 | ₹308,307,901,050.00 | ₹499,753.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,623.90 | ₹164,909,763,409.00 | ₹1,126,716.00 |
| HealthCare Global Enterprises Limited | HCG | ₹561.40 | ₹78,267,581,000.00 | ₹67,623.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹632.65 | ₹60,958,582,691.00 | ₹591,061.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹468.45 | ₹42,944,216,850.00 | ₹88,245.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹242.00 | ₹33,613,800,000.00 | ₹53,257.00 |
Key Executives
Gender: male
Year Born: 1967
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1976
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1962
Gender: male
Year Born: 1953
Gender: male
Year Born:
FAQs about Fortis Healthcare Limited
The CEO is Ashutosh Raghuvanshi.
The current price is ₹846.55.
The range is ₹480.55-849.7.
The market capitalization is ₹63,910.97 crores.
The P/E ratio is 82.41.
The company operates in the Healthcare sector.
Overview of Fortis Healthcare Limited (ISIN: INE061F01013) is a leading Medical - Care Facilities in India. With a market capitalization of ₹63,910.97 crores and an average daily volume of 1,819,770 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹1.